![Pharmacokinetic and Safety Profile of the Novel HIV Nonnucleoside Reverse Transcriptase Inhibitor MK-8507 in Adults without HIV | Antimicrobial Agents and Chemotherapy Pharmacokinetic and Safety Profile of the Novel HIV Nonnucleoside Reverse Transcriptase Inhibitor MK-8507 in Adults without HIV | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.00935-21/asset/259ab8aa-d52d-4bd2-8c04-8618895c984d/assets/images/large/aac.00935-21-f002.jpg)
Pharmacokinetic and Safety Profile of the Novel HIV Nonnucleoside Reverse Transcriptase Inhibitor MK-8507 in Adults without HIV | Antimicrobial Agents and Chemotherapy
![MK-8507 plasma PK following administration of single oral MK-8507 doses... | Download Scientific Diagram MK-8507 plasma PK following administration of single oral MK-8507 doses... | Download Scientific Diagram](https://www.researchgate.net/publication/354565004/figure/fig1/AS:1108577276174336@1641316827728/MK-8507-plasma-PK-following-administration-of-single-oral-MK-8507-doses-in-adults-without_Q320.jpg)
MK-8507 plasma PK following administration of single oral MK-8507 doses... | Download Scientific Diagram
![Safety, Tolerability and Pharmacokinetics Following Single- and Multiple-Dose Administration of the Novel NNRTI MK-8507 With a Midazolam Interaction Arm Safety, Tolerability and Pharmacokinetics Following Single- and Multiple-Dose Administration of the Novel NNRTI MK-8507 With a Midazolam Interaction Arm](https://www.natap.org/2020/images/101220/101220-3/1012201.gif)